LYTIR

Company · DTIL

Precision BioSciences, Inc.

Name as listed on its exchange; filed with the SEC as PRECISION BIOSCIENCES INC.

Nasdaq's symbol directory lists DTIL on Nasdaq as “Precision BioSciences, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 3 occasions ($30K); insiders sold on 1 occasion ($28K); 3 planned-sale notices; 4 filings by holders of 5% or more; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 38

Insider purchases and sales, by month (last 12 months)Insider purchases: $30K in total; Insider sales: $28K in total.Sep: Insider purchases $30KNov: Insider sales $28KDecJanFebMarAprMayJunJulAugSepOctNov$30K$28K
Insider purchases above the line: $30KInsider sales below: $28K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Scimeca Dario, Chief Legal Officer sold on 1 day all under a 10b5-1 plan latest Nov 10, 2026 sold $28K
  2. Geno J. Germano bought on 1 day latest Sep 25, 2026 bought $16K
  3. Melinda Brown bought on 1 day latest Sep 25, 2026 bought $7K
  4. Frankel Stanley bought on 1 day latest Sep 28, 2026 bought $6K
Every trade (4)
  1. SELLScimeca Dario, Chief Legal Officer sold Nov 10, 2026 2,821 shares 10b5-1 plan (scheduled) filing $28K
  2. BUYFrankel Stanley bought Sep 28, 2026 1,000 shares filing $6K
  3. BUYGeno J. Germano bought Sep 25, 2026 2,609 shares filing $16K
  4. BUYMelinda Brown bought Sep 25, 2026 1,135 shares filing $7K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Scimeca Dario filed Nov 10, 2026 Officer 2,821 shares planned sale date 11/10/2026 filing $28K
  2. SMITH J. JEFFERSON filed Nov 6, 2026 Officer 875 shares planned sale date 11/06/2026 filing $9K
  3. SMITH J. JEFFERSON filed Nov 5, 2026 Officer 7,056 shares planned sale date 11/05/2026 filing $72K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Octagon Capital Advisors LP filed Nov 3, 2026 Schedule 13G/A passive 1,651,497 shares filing 5.73%
  2. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G passive 1,384,230 shares filing 5.01%
  3. Weinstein Benjamin filed Aug 24, 2026 Schedule 13G/A passive filing 4%
  4. Lynx1 Capital Management LP filed Jul 20, 2026 Schedule 13G passive filing 5.4%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Nov 9, 2026
  2. Other events filing Nov 6, 2026
  3. Regulation FD disclosure; Other events filing Nov 5, 2026
  4. Results of operations and financial condition filing Nov 3, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.